A Study of YL202 in Selected Patients With Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2028-11-01
Target enrollment:
Participant gender:
Summary
This study is a multicenter, open-label, phase II study of YL202 in China to evaluate the
efficacy, safety, and PK characteristics of YL202 in the following selected patients with
advanced solid tumors.